An implantable intravenous infusion port

By designing the catheter and catheter lock of the Venturi structure in the implantable intravenous infusion port, the problem of drug damage to blood vessels caused by insufficient flow rate of the intravenous catheter is solved, the rapid dilution and spread of the drug solution is achieved, and the infusion efficiency is improved .

CN117224768BActive Publication Date: 2024-11-26JIANGSU YIBEI MEDICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311017642.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-08-14
Publication Date
2024-11-26
Estimated Expiration
2043-08-14

AI Technical Summary

Technical Problem

In the existing implantable intravenous infusion port, the flow rate of the intravenous fluid in the intravenous catheter is small, and irritating drugs such as chemotherapy drugs and nutritional support drugs cannot be quickly diluted and spread, resulting in damage to the patient's blood vessels.

Method used

An implantable intravenous infusion port was designed, including a port seat, a puncture membrane and a catheter. The catheter consists of the first tube body and the second tube body. The Venturi structure is formed at the connection between the two tube bodies, and the Venturi structure of the catheter lock is accelerated. The delivery of the medicine liquid ensures the rapid dilution and spread of the medicine liquid.

Benefits of technology

By increasing the flow rate of the medicine, the damage to the patient's blood vessels is reduced, the efficiency of intravenous infusion is improved, and the flow rate of the medicine is increased multiple times at different locations to maintain a rapid flow rate.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117224768B_ABST
    Figure CN117224768B_ABST
Patent Text Reader

Abstract

The present application provides an implantable intravenous infusion port, which includes a port seat, a puncture membrane and a catheter, wherein the top of the port seat is concave to form a liquid storage cavity; the puncture membrane is connected to the top of the port seat and covers the liquid storage cavity; the catheter is connected to the port seat and communicates with the liquid storage cavity; wherein the catheter includes a first tube body and a second tube body connected, one end of the first tube body is connected to the port seat, and the other end thereof is connected to the second tube body, the inner diameter of the first tube body is larger than the inner diameter of the second tube body, and a venturi structure is formed at the connection between the first tube body and the second tube body, so as to solve the technical problem that when the flow rate of the liquid medicine in the intravenous catheter is low, irritant drugs such as chemotherapy drugs and nutritional support drugs cannot be quickly diluted and spread, resulting in the irritant drugs causing certain damage to the patient's blood vessels.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of medical equipment technology, and in particular to an implantable intravenous infusion port. Background Art

[0002] An implantable venous access port (IVAP) is a fully implanted infusion drug delivery system buried in the human body, also known as an implantable drug delivery device. An implantable venous access port consists of a port for puncture and a venous catheter system. The end of the venous catheter is connected to the port. The port and the venous catheter are completely buried in the body, with the characteristics of long retention time and few complications. After the infusion port is implanted, the patient's daily life can be unrestricted and the quality of life can be improved.

[0003] The intravenous catheter can quickly dilute the drug concentration and avoid irritation and damage to the blood vessel wall. In actual clinical practice, the puncture needle needs to be used in conjunction with the infusion port. When the drug solution needs to be injected, the puncture needle is inserted into the port seat to form a needle channel in the port seat. After the puncture needle passes through the needle channel and injects the drug solution into the liquid storage cavity in the infusion port, the intravenous catheter then injects the drug solution into the patient's body. In this way, the infusion port can be used for drug infusion, fluid replacement, nutritional support, blood transfusion and other treatments, and can also be used for blood sample collection.

[0004] The tip of the venous catheter in the existing infusion port is located in the superior vena cava. When the flow rate of the drug in the venous catheter is low, irritating drugs such as chemotherapy drugs and nutritional support drugs cannot be diluted and spread quickly, causing the irritating drugs to cause certain damage to the patient's blood vessels. Summary of the invention

[0005] The present application provides an implantable intravenous infusion port to solve the technical problem that when the flow rate of the drug solution in the intravenous catheter is low, irritating drugs such as chemotherapy drugs and nutritional support drugs cannot be quickly diluted and spread, causing the irritating drugs to cause certain damage to the patient's blood vessels.

[0006] The present application provides an implantable intravenous infusion port, which includes a port seat, a puncture membrane and a catheter, wherein the top of the port seat is concave to form a liquid storage cavity; the puncture membrane is connected to the top of the port seat and covers the liquid storage cavity; the catheter is connected to the port seat and communicates with the liquid storage cavity; wherein the catheter includes a first tube body and a second tube body connected, one end of the first tube body is connected to the port seat, and the other end thereof is connected to the second tube body, the inner diameter of the first tube body is larger than the inner diameter of the second tube body, and a venturi structure is formed at the connection between the first tube body and the second tube body.

[0007] Optionally, the implantable intravenous infusion port also includes a catheter lock, which has a through hole axially extending therethrough, and the catheter lock includes a first locking segment, a second locking segment, and a third locking segment connected in sequence; the first locking segment is connected to the port seat, and the third locking segment is connected to the first tube body, so that the catheter is connected to the liquid storage chamber through the catheter lock; the aperture of the first locking segment is larger than the aperture of the second locking segment, and the aperture of the third locking segment is larger than the aperture of the second locking segment, so that the first locking segment, the second locking segment and the third locking segment form a Venturi structure.

[0008] Optionally, the third locking section includes an inner tube, an outer tube and a locking piece, and the inner tube is connected to the second locking section; the outer tube includes a tube body and at least two fixing parts, the tube body is connected to the outer wall of the inner tube, the fixing parts are arranged along the circumference of the inner tube, and there is a distance between two adjacent fixing parts; one end of each of the fixing parts is connected to the tube body, and the other end thereof extends obliquely in a direction away from the second locking section, so that there is a gap between the fixing part and the inner tube; the locking piece is sleeved on the outside of the outer tube, the fixing part is provided with an external thread, and the locking piece is provided with an adaptive internal thread; wherein, the first tube body can extend between the inner tube and the outer tube, and the locking piece is threadedly connected to the fixing part, so that the multiple fixing parts are close to each other and press the first tube body.

[0009] Optionally, a closing component is provided in the first locking segment, and the closing component includes two baffles and two spring sheets, and the two baffles are symmetrically arranged in the first locking segment, one end of the baffle is hinged to the inner wall of the first locking segment, and the other end thereof extends obliquely to the central axis of the first locking segment, so that the ends of the two baffles are close to each other; the spring sheet is arranged between the baffle and the first locking segment to assist the baffle in resetting.

[0010] Optionally, the baffle includes an arc-shaped main body and a straight end, and the straight end is arranged at one end of the arc-shaped main body; when the two baffles are close to each other, the two arc-shaped main bodies fit together, and the two straight ends form a duckbill structure.

[0011] Optionally, the pressing sheet is arc-shaped, a convex surface of the pressing sheet is connected to the blocking sheet, one end of the pressing sheet is connected to the inner wall of the first locking segment, and the other end thereof is slidably connected to the first locking segment.

[0012] Optionally, the density of the catheter is the same as the density of blood.

[0013] Optionally, the catheter is flat, and when the drug solution flows into the catheter, the catheter becomes round.

[0014] Optionally, at least two positioning marks are evenly distributed on the top of the port seat.

[0015] Optionally, the port seat is made of ceramic.

[0016] The present application provides an implantable intravenous infusion port. When a drug solution flows from a first tube body to a second tube body, the flow velocity of the drug solution increases at the junction of the first tube and the second tube body and inside the second tube due to the reduction in the area of ​​the flow cross street, thereby generating a pressure difference, so that the drug solution is sucked into the second tube body more quickly. Therefore, when the drug solution flows from the first tube diameter through the second tube diameter, the flow velocity of the drug solution increases, so that irritating drugs can be quickly diluted and spread, thereby reducing the damage caused by the drug to the patient's blood vessels.

[0017] The Venturi structure at the catheter lock can be used to quickly transport the liquid medicine in the liquid storage cavity to the inside of the catheter, and at the same time, the Venturi structure at the catheter can be used to quickly transport the liquid medicine in the catheter to the inside of the blood vessel, so that the liquid medicine can be quickly diluted and transported, thereby improving the infusion efficiency of the intravenous infusion port. At the same time, the catheter lock and the Venturi structure at the catheter can increase the flow rate of the liquid medicine multiple times at different positions, so that the liquid medicine can maintain a fast flow rate after being output from the liquid storage cavity and flow into the blood vessel. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] In order to more clearly illustrate the technical solutions in the embodiments of the present application, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For those skilled in the art, other drawings can be obtained based on these drawings without creative work.

[0019] Figure 1 It is a schematic diagram of an explosion of an implantable intravenous infusion port provided by the present application;

[0020] Figure 2 is a cross-sectional view of a catheter lock in an implantable intravenous infusion port provided by the present application;

[0021] Figure 3 It is a schematic diagram of the connection between the catheter lock and the catheter in the implantable intravenous infusion port provided in the present application.

[0022] Description of reference numerals:

[0023] 100, port seat; 110, puncture membrane; 120, positioning mark; 200, catheter; 210, first tube body; 220, second tube body; 300, catheter lock; 310, first locking section; 320, second locking section; 330, outer tube; 331, tube body; 332, fixing part; 340, inner tube; 350, locking piece; 410, baffle; 411, arc-shaped body; 412, straight end; 420, spring piece. DETAILED DESCRIPTION

[0024] The technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without making creative work are within the scope of protection of the present application. In addition, it should be understood that the specific implementation methods described herein are only used to illustrate and explain the present application and are not used to limit the present application. In the present application, unless otherwise stated, the directional words used, such as "up", "down", "left", and "right", generally refer to the up, down, left, and right of the device in actual use or working state, specifically the drawing direction in the accompanying drawings.

[0025] The present application provides an implantable intravenous infusion port, which is described in detail below. It should be noted that the description order of the following embodiments does not limit the preferred order of the embodiments of the present application. In the following embodiments, the description of each embodiment has its own emphasis. For parts that are not described in detail in a certain embodiment, please refer to the relevant description of other embodiments.

[0026] See also Figure 1 The present application provides an implantable intravenous infusion port, which is a fully implanted vascular access system that can provide patients with long-term intravenous vascular access. The implantable intravenous infusion port includes a port seat 100, a puncture membrane 110, and a catheter 200. The port seat 100 is concave along its top to form a liquid storage cavity for containing liquid medicine. In order to improve the safety of drugs and avoid affecting radiotherapy, the material of the port seat 100 in the present application is preferably ceramic.

[0027] The puncture membrane 110 is connected to the top of the port seat 100 and can completely cover the liquid storage cavity. The puncture membrane 110 can be made of a silicone septum with a thickness of more than 2 cm. When punctured with a non-destructive needle, it can withstand 2000 non-destructive punctures at 22G and 1000 non-destructive punctures at 20G.

[0028] See also Figure 1 One end of the catheter 200 is connected to the port 100, so that the catheter 200 is connected to the liquid storage cavity, and the other end of the catheter 200 is inserted into the blood vessel, so that the liquid medicine in the liquid storage cavity can be transported into the blood vessel. In this embodiment, the density of the catheter 200 is the same as the blood concentration at the placement site, so that the catheter 200 can be suspended in the middle of the blood vessel, thereby preventing the catheter 200 from contacting the blood vessel wall and preventing the catheter 200 from causing adverse effects on the blood vessel wall.

[0029] See also Figure 1The catheter 200 is a flat structure. When the drug solution flows into the interior of the catheter 200, the catheter 200 is expanded under the action of the drug solution, so that the catheter 200 is expanded into a round shape. After the infusion is completed, the catheter 200 returns to its flat shape, thereby preventing blood from flowing back into the catheter 200 after the infusion is completed.

[0030] See also Figure 1 The catheter 200 includes a first tube body 210 and a second tube body 220 connected at the ends, wherein one end of the first tube body 210 is connected to the port seat 100, and the other end thereof is connected to the second tube body 220, portions of the first tube body 210 and the second tube body 220 are both inserted into the interior of the blood vessel, and the end of the second tube body 220 is located in the superior vena cava.

[0031] See also Figure 1 , the second tube body 220 is located at the end of the catheter 200, so the length of the first tube body 210 is greater than the length of the second tube body 220. The inner diameter of the first tube body 210 is greater than the inner diameter of the second tube body 220, and the junction of the first tube body 210 and the second tube body 220 forms a Venturi structure. When the liquid medicine flows from the first tube body 210 to the second tube body 220, the dynamic pressure reaches the maximum value and the static pressure reaches the minimum value at the junction of the first tube body 210 and the second tube body 220 and inside the second tube body 220, and the flow rate of the liquid medicine increases due to the reduction in the area of ​​the circulation cross street. The entire flow must undergo the pipeline contraction process at the same time, so the pressure also decreases at the same time, thereby generating a pressure difference, so that the liquid medicine is sucked into the second tube body 220 more quickly.

[0032] Since the inner diameter of the first tube body 210 is greater than that of the second tube body 220 , the end of the first tube body 210 gradually shrinks and is connected to the second tube body 220 , so that a Venturi structure is formed at the junction of the first tube body 210 and the second tube body 220 .

[0033] See also Figure 1 When the flow rate of the liquid medicine in the catheter 200 is low, irritating drugs such as chemotherapy drugs and nutritional support drugs cannot be quickly diluted and spread, thereby causing certain damage to the patient's blood vessels by the irritating drugs. Since the diameter of the second tube body 220 is smaller than the diameter of the first tube body 210, when the liquid medicine flows from the first tube body 210 to the second tube body 220, the flow rate of the liquid medicine increases, so the irritating drugs (chemotherapeutic drugs, nutritional support drugs, etc.) can be quickly diluted and spread, thereby reducing the damage caused by the drugs to the patient's blood vessels.

[0034] See also Figure 1 and Figure 3A catheter lock 300 is provided at the connection between the catheter 200 and the port seat 100. The catheter lock 300 has a through hole extending through the axial direction thereof, so that the catheter 200 is connected to the liquid storage cavity. The catheter lock 300 includes a first lock segment 310, a second lock segment 320 and a third lock segment connected in sequence. The first lock segment 310 is connected to the port seat 100, and the third lock segment is connected to the first tube body 210, so that the port seat 100 and the first tube body 210 can be connected.

[0035] See also Figure 1 and Figure 2 , the aperture of the first lock segment 310 is larger than the aperture of the second lock segment 320, and the aperture of the third lock segment is larger than the aperture of the second lock segment 320, so that the first lock segment 310, the second lock segment 320 and the third lock segment form a Venturi structure. When the liquid medicine flows from the liquid storage chamber to the catheter 200, the internal dynamic pressure of the second lock segment 320 reaches the maximum value, the static pressure reaches the minimum value, and the flow rate of the liquid medicine increases due to the reduction in the area of ​​the circulation cross street. The entire flow must undergo the pipeline contraction process at the same time, so the pressure also decreases at the same time, thereby generating a pressure difference, so that the liquid medicine is sucked into the third lock segment and the catheter 200 more quickly, thereby accelerating the flow of the liquid medicine into the patient's blood vessels.

[0036] When the flow rate of the liquid medicine in the catheter 200 is low, irritating drugs such as chemotherapy drugs and nutritional support drugs cannot be quickly diluted and spread, thereby causing certain damage to the patient's blood vessels by the irritating drugs. Since the aperture of the first lock segment 310 is larger than the aperture of the second lock segment 320, and the aperture of the third lock segment is larger than the aperture of the second lock segment 320, when the liquid medicine flows from the first lock segment 310 to the second lock segment 320, the flow rate of the liquid medicine increases, so the irritating drugs (chemotherapeutic drugs, nutritional support drugs, etc.) can be quickly diluted and spread, thereby reducing the damage caused by the drugs to the patient's blood vessels.

[0037] See also Figure 1-Figure 3 In the present application, the junction of the first tube body 210 and the second tube body 220 forms a Venturi structure, and the first locking segment 310, the second locking segment 320 and the third locking segment form a Venturi structure. The Venturi structure at the catheter lock 300 can quickly transport the liquid medicine in the liquid storage cavity to the inside of the catheter 200, and at the same time, the Venturi structure at the catheter 200 can quickly transport the liquid medicine in the catheter 200 to the inside of the blood vessel, so that the liquid medicine can be quickly diluted and transported, thereby improving the infusion efficiency of the intravenous infusion port. At the same time, the catheter lock 300 and the Venturi structure at the catheter 200 can increase the flow rate of the liquid medicine multiple times, so that the liquid medicine can maintain a fast flow rate after being output from the liquid storage cavity.

[0038] Due to the obvious difference in the internal dimensions of the liquid storage chamber, the catheter lock 300 and the catheter 200, the liquid medicine ejected from the syringe has a relatively large flow velocity. However, since the communicating area between the liquid storage chamber and the catheter lock 300 is significantly smaller than the cross-sectional area of ​​the liquid storage chamber, the flow velocity of the liquid medicine in the liquid storage chamber is significantly reduced when it flows to the catheter lock 300. At this time, the Venturi structure at the catheter lock 300 can not only assist the liquid medicine in the liquid storage chamber to flow to the inside of the catheter lock 300, but also increase the flow velocity of the liquid medicine in the catheter lock 300 when it flows to the inside of the catheter 200, thereby achieving the first acceleration of the liquid medicine. Due to the long length of the catheter 200, the flow velocity of the liquid medicine in the catheter 200 will be reduced when it flows inside the catheter 200. When the liquid medicine flows to the connection at the outlet of the catheter 200, the Venturi structure can not only assist the liquid medicine in the catheter 200 to flow to the inside of the blood vessel, but also increase the velocity of the liquid medicine when it flows out of the catheter 200, thereby achieving the second acceleration of the liquid medicine. Therefore, the Venturi structure arranged at different positions can reduce the damage caused by the drug to the blood vessel.

[0039] See also Figure 1-Figure 3 The third locking section includes an inner tube 340 and an outer tube 330, wherein the inner tube 340 is connected to the second locking section 320, so that the third locking section is connected to the second locking section 320. The outer tube 330 includes a tube body 331 and at least two fixing portions 332, wherein the tube body 331 is connected to the outer wall of the inner tube 340, and all the fixing portions 332 are arranged along the circumference of the inner tube 340. One end of each fixing portion 332 is connected to the end of the tube body 331, and the other end of the fixing portion 332 extends obliquely in a direction away from the second locking section 320. The central axis of the tube body 331 and the central axis of the inner tube 340 are located on the same straight line, and there is a gap between the fixing portion 332 and the inner tube 340, and the gap is slightly larger than the tube wall thickness of the first tube body 210, so that the first tube body 210 can extend between the inner tube 340 and the outer tube 330.

[0040] The inclined fixing portion 332 not only facilitates the insertion of the first tube body 210 between the outer tube 330 and the inner tube 340, but can also be adapted to first tube bodies 210 of various specifications, thereby facilitating the connection of the port seat 100 with catheters 200 of various specifications, so that the implantable intravenous infusion port can be suitable for a variety of application scenarios.

[0041] See also Figure 1-Figure 3The third locking section also includes a locking member 350, which is sleeved on the outside of the outer tube 330 and is threadedly connected to the fixing portion 332, wherein the fixing portion 332 is provided with an external thread, and a matching internal thread is provided in the locking member 350. When the end of the first tube 210 extends between the outer tube 330 and the inner tube 340, the locking member 350 is fixed to the outside of the fixing portion 332 by threading. Since one end of the fixing portion 332 is connected to the tube 331 and the other end thereof extends obliquely, when the locking member 350 is threadedly connected to the outside of the fixing portion 332, the locking member 350 drives the plurality of fixing portions 332 to approach each other, so that the fixing portions 332 can be pressed onto the first tube 210, thereby realizing the fixed connection between the catheter lock 300 and the first tube 210.

[0042] By utilizing the combination of the inner tube 340 , the outer tube 330 and the locking member 350 , the specifications of the catheter 200 that the port seat 100 can be increased, and the catheter lock 300 and the catheter 200 can be quickly fixed, thereby improving the assembly efficiency of the intravenous infusion port.

[0043] See also Figure 2 and Figure 3 The first locking segment 310 is provided with a sealing component, which can seal the space in the first locking segment 310 so that the blood in the blood vessel cannot flow back into the liquid storage chamber. The sealing component includes two baffles 410 and two springs 420, which are symmetrically arranged inside the first locking segment 310, wherein one end of each baffle 410 is hinged to the inner wall of the first locking segment 310, and the other end thereof is obliquely extended to the central axis of the first locking segment 310, so that the ends of the two baffles 410 can be close to each other, thereby sealing the inside of the first locking segment 310.

[0044] Each baffle 410 is connected to the inside of the first locking section 310 through an elastic sheet 420, so that the elasticity of the elastic sheet 420 is used to assist the baffle 410 in resetting. The elastic sheet 420 is an arc-shaped structure, and the convex surface of the elastic sheet 420 is connected to the baffle 410, so that the elastic sheet 420 is fixed to the baffle 410. One end of the elastic sheet 420 is connected to the inner wall of the first locking section 310, and the other end thereof is slidably connected to the first locking section 310, so as to prevent the elastic sheet 420 from being separated from the first locking section 310.

[0045] See also Figure 1-Figure 3In the initial state, the spring sheet 420 is in an uncompressed state, and the end of the baffle 410 extends obliquely to the center of the first locking section 310, so that the ends of the two baffles 410 are close to each other, so that the two baffles 410 can be used to prevent the blood in the blood vessel from flowing back into the liquid storage chamber. When the liquid medicine in the liquid storage chamber flows into the catheter 200, the liquid medicine applies pressure to the baffle 410, so that the baffle 410 is close to the inner wall of the first locking section 310 under the action of pressure. At this time, the baffle 410 applies a pressure to the spring sheet 420, so that the two ends of the spring sheet 420 are gradually separated, and the spring sheet 420 is in a compressed state. When the liquid medicine in the liquid storage chamber flows into the blood vessel, the pressure acting on the baffle 410 disappears. At this time, the spring sheet 420 can convert its own elastic force into a thrust to drive the baffle 410 to move, so that the two baffles 410 can be reset to the initial state, thereby preventing the blood in the blood vessel from flowing back into the catheter 200 and the liquid storage chamber.

[0046] See also Figure 2 and Figure 3 The baffle 410 includes an arc-shaped body 411 and a straight end 412, wherein one end of the arc-shaped body 411 is rotatably connected to the inside of the first locking section 310, and the straight end 412 is located at the other end of the arc-shaped body 411. When the two baffles 410 are close to each other, the two arc-shaped bodies 411 can fit together, and the two straight ends 412 are close to each other to form a duckbill structure.

[0047] When the blood in the blood vessel flows back into the catheter lock 300, since the arc-shaped main body 411 of the baffle 410 fits together and the two straight ends 412 are close to each other to form a duckbill structure, the blood will apply pressure to the baffle 410, so that the two arc-shaped main bodies 411 fit more closely under the action of the above pressure, and the two straight ends 412 fit together under the action of the above pressure, so that the interior of the first lock segment 310 is sealed by the two baffles 410, thereby preventing blood from flowing back into the liquid storage chamber.

[0048] See also Figure 1 At least two positioning marks 120 are evenly distributed on the top of the port seat 100. The positioning marks 120 can be identification lights, color dots with strong contrast, or other identifiable and harmless objects.

[0049] The angle between adjacent positioning markers 120 is 90°, which can ensure the accuracy and efficiency of the position judgment of the positioning markers 120, so that after the position of one pair of positioning markers 120 is determined, the remaining positioning markers 120 are also determined accordingly, without wasting too much time on the problem of position determination, thereby improving positioning accuracy and efficiency.

[0050] The above is a detailed introduction to an implantable intravenous infusion port provided by the present application. Specific examples are used in this article to illustrate the principles and implementation methods of the present application. The description of the above embodiments is only used to help understand the method of the present application and its core idea. At the same time, for a person skilled in the art, according to the idea of ​​the present application, there will be changes in the specific implementation method and application scope. In summary, the content of this specification should not be understood as a limitation on the present application.

Claims

1. An implantable intravenous infusion port, characterized in that: include: The port seat has a concave top to form a liquid storage cavity; a puncture membrane connected to the top of the port seat and covering the liquid storage cavity; and a catheter connected to the port seat and communicated with the liquid storage chamber; wherein the catheter comprises a first tube body and a second tube body connected, one end of the first tube body is connected to the port seat, and the other end thereof is connected to the second tube body, the inner diameter of the first tube body is larger than the inner diameter of the second tube body, and the connection between the first tube body and the second tube body forms a Venturi structure; A catheter lock, which has a through hole extending axially therethrough, and comprises a first lock segment, a second lock segment and a third lock segment connected in sequence; the first lock segment is connected to the port seat, and the third lock segment is connected to the first tube body, so that the catheter is connected to the liquid storage chamber through the catheter lock; the aperture of the first lock segment is larger than the aperture of the second lock segment, and the aperture of the third lock segment is larger than the aperture of the second lock segment, so that the first lock segment, the second lock segment and the third lock segment form a Venturi structure; The third locking section comprises: an inner tube, which is connected to the second locking section; an outer tube, which comprises a tube body and at least two fixing parts, the tube body is connected to the outer wall of the inner tube, the fixing parts are arranged along the circumferential direction of the inner tube, and there is a distance between two adjacent fixing parts; one end of each of the fixing parts is connected to the tube body, and the other end thereof extends obliquely in a direction away from the second locking section, so that there is a gap between the fixing part and the inner tube; and a locking member, which is sleeved to the outside of the outer tube, the fixing part is provided with an external thread, and the locking member is provided with an adapted internal thread; wherein the first tube body can extend between the inner tube and the outer tube, and the locking member is threadedly connected to the fixing part, so that a plurality of the fixing parts are close to each other and press the first tube body; A closing assembly is provided in the first locking section, and the closing assembly includes: two baffles, which are symmetrically arranged in the first locking section, one end of the baffle is hinged to the inner wall of the first locking section, and the other end of the baffle is obliquely extended to the central axis of the first locking section, so that the ends of the two baffles are close to each other; and two springs, which are arranged between the baffles and the first locking section to assist the baffles in resetting; The baffle comprises: an arc-shaped main body; and a straight end portion, which is arranged at one end of the arc-shaped main body; when the two baffles are close to each other, the two arc-shaped main bodies fit together, and the two straight end portions form a duckbill structure.

2. The implantable intravenous port according to claim 1, characterized in that: The spring sheet is arc-shaped, a convex surface of the spring sheet is connected to the blocking sheet, one end of the spring sheet is connected to the inner wall of the first locking section, and the other end thereof is slidably connected to the first locking section.

3. The implantable intravenous port according to claim 1, characterized in that: The density of the catheter is the same as the density of blood.

4. The implantable intravenous port according to claim 1, characterized in that: The catheter is flat, and when the drug solution flows into the catheter, the catheter is expanded into a round shape.

5. The implantable intravenous port according to claim 1, characterized in that: At least two positioning marks are evenly distributed on the top of the port seat.

6. The implantable intravenous port according to claim 1, characterized in that: The material of the port seat is ceramic.